Verubulin (MPC-6827) is a highly effective, broad-spectrum microtubule blocker with in vivo and in vitro cytotoxic activity, promising as a potential drug candidate for a wide range of cancers.
Chebulagic acid is a dual inhibitor of COX-LOX extracted from the fruit. Has anti-inflammatory and anti-infective effects. Chebulagic acid is an M2(S31N) inhibitor and anti-influenza virus agent. Chebulagic acid also inhibits replication of the SARS-CoV-2 virus,EC50 The value is 9.76 μM.
Chebulagic acid is a dual inhibitor of COX-LOX extracted from the fruit. Has anti-inflammatory and anti-infective effects. Chebulagic acid is an M2(S31N) inhibitor and anti-influenza virus agent. Chebulagic acid also inhibits replication of the SARS-CoV-2 virus,EC50 The value is 9.76 μM.
WEHI-9625 is a first-in-class tricyclic sulfone, first-in-class inhibitor of apoptosis with an EC50 of 69 nM. WEHI-9625 binds to VDAC2 and promotes its ability to inhibit apoptosis driven by mouse BAK. WEHI-9625 is completely inactive against both human BAK and the closely related apoptosis effector BAX.
WEHI-9625 is a first-in-class tricyclic sulfone, first-in-class inhibitor of apoptosis with an EC50 of 69 nM. WEHI-9625 binds to VDAC2 and promotes its ability to inhibit apoptosis driven by mouse BAK. WEHI-9625 is completely inactive against both human BAK and the closely related apoptosis effector BAX.
(+)-(3R, 8S)-Falcarindiol is polyacetylene obtained from carrots, has an antimycobacterial effect, the lowest inhibitory concentration of Mycobacterium tuberculosis H37Ra MIC and IC50 The values are 24 μM and 6 μM, respectively. Has anti-tumor and anti-inflammatory effects.
CPI-1189 (REN 1654, REN 1189) is an inhibitor of tumor necrosis factor (TNF) alpha. CPI-1189 inhibits the phosphorylation activation of protein kinase activated by p38 mitogens in cells and plays a neuroprotective role.
Mezigdomide (CC-92480) is a novel protein reducing agent and cereblon E3 ligase modulator (CELMoD). Mezigdomide has a strong affinity with Cereblon and has anti-myeloma activity.
Mezigdomide (CC-92480) is a novel protein reducing agent and cereblon E3 ligase modulator (CELMoD). Mezigdomide has a strong affinity with Cereblon and has anti-myeloma activity.
Mezigdomide (CC-92480) is a novel protein reducing agent and cereblon E3 ligase modulator (CELMoD). Mezigdomide has a strong affinity with Cereblon and has anti-myeloma activity.
Mezigdomide (CC-92480) is a novel protein reducing agent and cereblon E3 ligase modulator (CELMoD). Mezigdomide has a strong affinity with Cereblon and has anti-myeloma activity.
Vasopressin is a cyclic nine-peptide synthesized in the hypothalamus center. Vasopressin participates in the hypothalamic-pituitary-adrenal axis and regulates pituitary corticotropin secretion by enhancing the stimulating effect of corticotropin-releasing factor. Vasopressin can also act as a neurotransmitter, acting by binding to specific...